Please assess the completion status of the following clinical trial:

Trial Title: Application of Vitamin E on Anal Fissure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with diagnosis of chronic anal fissure~Exclusion Criteria:~* patients with associated anal pathologies~* intestinal inflammation disorders~* immunosuppression~* fissures secondary to underlying diseases (eg, AIDS, tuberculosis, or sexually transmitted diseases)~* patients with a history of headaches, heart disease, or intolerance to nitrates~* pregnant or lactating women~* patients with closed angle glaucoma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vitamin E acetate (Type: EXPERIMENTAL): Commercially available plastic tubes containing vitamin E acetate ointment (Filme Olio, Hulka SRL, Italy) were purchased from pharmacies. The dosage for all the patients was 1ml of ointment (containing 1100% vitamin E), applied with a gloved finger to the distal anal canal, every 12 hours for an 8-week period.
- Glyceryl trinitrate ointment (Type: ACTIVE_COMPARATOR): Commercially available aluminium tubes containing 0.4 glyceryl trinitrate ointment (Rectogesic, proStrakan Group, Galashiels, UK) were purchased from pharmacies. The dosage for all the patients was 375 mg of ointment (containing 1.5 mg of glyceryl trinitrate), applied with a gloved finger to the distal anal canal, every 12 hours for an 8-week period.

Based on this trial design, predict the completion outcome and termination type (if applicable).